Quest to acquire Lewisville, Texas-based Med Fusion and Clear Point to create a base in the southwestern United States for providing precision medicine diagnostics to aid cancer treatment and care

Telehealth aims to provide patients with a flexible route to quality care, yet many experiences go unrecorded. A study published in Annals of Family Medicine aimed to add to the research on patient telehealth experiences to improve development and personalization of telehealth.

Out of the $6 billion CMS made in Medicare electronic health records (EHR) incentive payments by June 2014, the HHS Office of the Inspector General (OIG) estimated $729 million was paid to professionals who didn’t meet meaningful use requirements.

eClinicalWorks®, a leader in healthcare IT solutions, announced today that its telehealth solution is now available on the company’s Health & Online Wellness (healow™) mobile app to provide patients with live video visits. This TeleVisits feature is integrated within the eClinicalWorks comprehensive electronic health records (EHR) offering and all information submitted or shared by patients using this solution can be imported into the EHR. This supports workflow, clinical research and improves patient satisfaction with access to care whenever and wherever it’s needed.

Data scientists form Microsoft have donated a newly developed research tool to Seattle Children’s Research Institute to advance research into sudden infant death syndrome (SIDS). The tool will also be available to researchers around the globe.

Surefire Medical, Inc., the developer of site-specific delivery devices for the Interventional Oncology market, announced today results from a retrospective analysis of 85 bridge-to-transplant liver cancer patients treated with transarterial chemoembolization (DEB-TACE) that shows therapy delivery with the Surefire Infusion System was associated with an 80 percent complete response in one treatment versus 52 percent with a standard endhole microcatheter. In addition, the analysis shows a statistically significant lower recurrence rate of liver cancer at one month of 13 percent using Surefire technology versus 52 percent recurrence with a standard microcatheter.

Apple has brought on Sumbul Desai, MD, for an undefined senior role which CNBC said “demonstrates that Apple is taking its health ambitions seriously.”

 Royal Philips (NYSE: PHG AEX: PHIA) today announced the relaunch of its innovative Pioneer Plus catheter, the first and only re-entry device with intravascular ultrasound (IVUS) capabilities and needle deployment designed to assist arterial vessel intervention. IVUS captures images of vessels in the peripheral vascular system from inside the artery, allowing physicians to identify a targeted area and place a catheter in a specific location and to help guide the treatment partially or fully blocked arteries.